Trial intelligence / Profile preview

Dronabinol for Fear Extinction in PTSD

NCT04080427Phase 1Completed

Sponsor
Wayne State University
Start
Apr 2021
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Dronabinol with Placebo (2 arms). Primary endpoints: Brain Measures, Psychophysiology and 4 more. Started Apr 2021; status: completed.

02

Drugs

dronabinol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT04080427.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04080427.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call